Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
MDWD
MDWD
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
MDWD News
MediWound Reports Q1 2026 Revenue Decline and Reaffirms Guidance
3d ago
NASDAQ.COM
MediWound Advances ESCAREX Program Towards Commercialization
4d ago
Yahoo Finance
Mediwound Shares Enter Oversold Territory
4d ago
NASDAQ.COM
MediWound Q1 Earnings Beat Expectations Despite Revenue Decline
4d ago
seekingalpha
MediWound to Announce Q1 Earnings on May 27
5d ago
seekingalpha
U.S. Expert Consensus Supports MediWound's Chronic Wound Treatment Strategy
Apr 13 2026
Newsfilter
MediWound Reports $197 Million BARDA Contract Award to Vericel for NexoBrid
Apr 02 2026
Newsfilter
MediWound Ltd. Q4 2025 Earnings Call Insights
Mar 05 2026
seekingalpha
MediWound Files Annual Report for FY2025
Mar 05 2026
Newsfilter
MediWound Q4 Earnings Beat Expectations Despite Revenue Decline
Mar 05 2026
seekingalpha
MediWound to Announce Q4 Earnings on March 5
Mar 04 2026
seekingalpha
MediWound Reports NexoBrid Reduces Traumatic Tattoo Risk by 92.5%
Dec 10 2025
Globenewswire
MediWound Reports NexoBrid's 92.5% Effectiveness in Preventing Traumatic Tattoos
Dec 10 2025
Newsfilter
Palo Alto Set to Surge by 30%? Check Out 10 Leading Analyst Predictions for Friday
Nov 21 2025
Benzinga
HC Wainwright & Co. Reaffirms Buy Rating for MediWound, Increases Price Target to $36
Nov 21 2025
Benzinga
MediWound Announces Financial Results for Q3 2025 and Shares Corporate Developments
Nov 20 2025
Newsfilter
Show More News
